1999;29:1251 1256. doi: 10.1086/313435. 157. Nannini EC, Singh KV, Murray BE. Relapse of type A beta-lactamase- producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis. 2003;37:1194 1198. doi: 10.1086/379021. 158. Watanakunakorn C. Clindamycin therapy of Staphylococcus aureus endocarditis: clinical relapse and development of resistance to clindamy- cin, lincomycin and erythromycin. Am J Med. 1976;60:419 425. 159. Mortara LA, Bayer AS. Staphylococcus aureus bacteremia and endocar- ditis: new diagnostic and therapeutic concepts. Infect Dis Clin North Am. 1993;7:53 68. 160. Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of dap- tomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191:2149 2152. doi: 10.1086/430352. 161. Le T, Bayer AS. Combination antibiotic therapy for infective endocardi- tis. Clin Infect Dis. 2003;36:615 621. doi: 10.1086/367661. 162. Riedel DJ, Weekes E, Forrest GN. Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus. Antimicrob Agents Chemother. 2008;52:2463 2467. doi: 10.1128/AAC.00300-08. 163. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991;115:674 680. 164. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR; Infectious Diseases Society of America. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:1 10. doi: 10.1093/cid/ cis966. 165. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim- sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med. 1992;117:390 398. doi: 10.7326/0003-4819-117-5-390. 166. Proctor RA. Role of folate antagonists in the treatment of methicillin- resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46:584 593. doi: 10.1086/525536. 167. Steed ME, Vidaillac C, Rybak MJ. 